US FDA Biosimilar Review Information Requests Should Come Earlier, With Longer Response Times

 
• By Sue Sutter
  
Alarm clock
FDA is being urged to extend the response clock for biosimilar application information requests. • Source: Alamy

More from Biosimilars

More from Products